Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

The MTX amplified monoclonal cell lines exhibited specific productivities in the range of 5 - 30 pg/ cell/day with volumetric titers of 10 - 140 mg/l (unpublished data). To conclude on the reviewed ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

Bio-Thera will obtain an upfront payment of $21m and could earn up to $143.5m in development and commercial milestones.

Researchers at McMaster University have made a discovery in the field of hematology, providing an explanation for spontaneous ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Researchers at McMaster University have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite ...

1 Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands Objectives Millions of patients worldwide are treated with therapeutic ...

half-life extended anti-immunoglobulin E monoclonal antibody. Rapt plans to pursue development of RPT904 initially in food allergy, which is a market that represents “a large and lucrative niche ...

In mid-2024, the patient underwent a kidney transplant. Though he was relatively young for a transplant, that’s not where he ...

Researchers observed an increase in both CXCR4 and CD5 levels as the cells progressed to later stages of the cell cycle, particularly in the S/G2/M phases.